Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.

Literature DB >> 18220307

The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.

Michael Adler, Béatrice Gulbis, Christophe Moreno, Sylvie Evrard, Gontran Verset, Philippe Golstein, Brigitte Frotscher, Nathalie Nagy, Philippe Thiry.

Abstract

Entities: Disease

Mesh：

Substances：
RNA, Viral

Year: 2008 PMID： 18220307 DOI： 10.1002/hep.22085

Source DB: PubMed Journal: Hepatology ISSN： 0270-9139 Impact factor: 17.425

Keyword Cloud
Cited

× No keyword cloud information.

36 in total

1. Liver fibrosis scores predict liver disease mortality in the United States population.

Authors: Aynur Unalp-Arida; Constance E Ruhl
Journal: Hepatology Date: 2017-05-16 Impact factor: 17.425

2. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.

Authors: Joseph K Lim; Janet P Tate; Shawn L Fultz; Joseph L Goulet; Joseph Conigliaro; Kendall J Bryant; Adam J Gordon; Cynthia Gibert; David Rimland; Matthew Bidwell Goetz; Marina B Klein; David A Fiellin; Amy C Justice; Vincent Lo Re
Journal: Clin Infect Dis Date: 2014-02-25 Impact factor: 9.079

Review 3. NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet?

Authors: Shivaram P Singh; Rakesh K Barik
Journal: J Clin Exp Hepatol Date: 2019-09-21

4. Role of simple biomarkers in predicting fibrosis progression in HCV infection.

Authors: Rajasekhara R Mummadi; John R Petersen; Shu-Yuan Xiao; Ned Snyder
Journal: World J Gastroenterol Date: 2010-12-07 Impact factor: 5.742

Review 5. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.

Authors: Dharmesh H Kaswala; Michelle Lai; Nezam H Afdhal
Journal: Dig Dis Sci Date: 2016-03-26 Impact factor: 3.199

6. The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.

Authors: Mark H Kuniholm; Xiaojiang Gao; Xiaonan Xue; Andrea Kovacs; Darlene Marti; Chloe L Thio; Marion G Peters; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Mary A Young; Howard D Strickler; Mary Carrington
Journal: J Infect Dis Date: 2011-06-15 Impact factor: 5.226

The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.

1. Liver fibrosis scores predict liver disease mortality in the United States population.

2. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.

Review 3. NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet?

4. Role of simple biomarkers in predicting fibrosis progression in HCV infection.

Review 5. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.

6. The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.

7. The treatment of hepatic encephalopathy in the cirrhotic patient.

Review 8. Role of liver biopsy in the era of direct-acting antivirals.

9. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.

Review 10. Chronic hepatitis C and liver fibrosis.